The Ratio of Metastatic/Resected Lymph Nodes is an Independent Prognostic Factor in Patients With Node-positive Pancreatic Head Cancer
Authors:
- Marek SierzegaMSMarek Sierzega
- Tadeusz PopielaTPTadeusz Popiela
- Jan KuligJKJan Kulig
- Krystyna NowakKNKrystyna Nowak
- 1 October 2006
- journal article
- Published by Wolters Kluwer Health in Pancreas
- Vol. 33 (3) , 240-245
Abstract
The aim of this study was to evaluate the prognostic value of nodal involvement in resected adenocarcinoma of the pancreatic head. For the period between 1980 and 2002, 96 patients underwent pancreaticoduodenectomy for pancreatic cancer. Lymph nodes were numbered and classified into groups according to the Japan Pancreatic Society rules. Metastatic lymph nodes were identified based on hematoxylin and eosin staining. Sixty-four (66.7%) patients had positive lymph nodes. The median number of metastatic nodes was 2 (95% confidence interval [CI], 1.0-3.0) and the median ratio of metastatic/resected nodes was 9.7% (95% CI, 7.1%-14.4%). The median survival was 14.2 months (95% CI, 10.7-17.7) and was significantly higher for node-negative than node-positive patients (27.9; 95% CI, 20.9-34.9 vs. 10.6; 95% CI, 8.7-12.5; P < 0.001). The Cox proportional hazards model, including all patients, demonstrated that nodal involvement (hazard ratio [HR], 1.461; 95% CI, 1.177-12.024), moderate or poor tumor differentiation (HR, 2.330; 95% CI, 1.181-6.949), and positive resection margins (HR, 3.838; 95% CI, 1.390-10.597) were independent negative prognostic factors. If the analysis was limited to node-positive patients, lymph node ratio of more than 20% (HR, 1.364; 95% CI, 1.116-2.599), moderate or poor tumor differentiation (HR, 3.393; 95% CI, 1.041-11.061), and positive resection margins (HR, 9.400; 95% CI, 2.235-39.536) significantly correlated with a poorer survival. Lymph node ratio seems to be a new promising prognostic factor in patients with respectable node-positive pancreatic head cancer.Keywords
This publication has 34 references indexed in Scilit:
- Molecular prognostic markers in pancreatic cancer: A systematic reviewEuropean Journal of Cancer, 2005
- Para-aortic lymph node metastasis in carcinoma of the head of the pancreasSurgery, 2005
- Lymphatic Staging in Colorectal Cancer: Pathologic, Molecular, and Sentinel Node TechniquesDiseases of the Colon & Rectum, 2005
- Number of lymph nodes examined and prognosis of TNM stage II colorectal cancerEuropean Journal of Cancer, 2005
- Mode of Spread in the Early Phase of Lymphatic Metastasis in Pancreatic Ductal AdenocarcinomaAnnals of Surgery, 2004
- Survival of patients with periampullary carcinoma is predicted by lymph node 8a but not by lymph node 16b1 statusBritish Journal of Surgery, 2004
- Extended Radical Resection Versus Standard Resection for Pancreatic CancerPancreas, 2004
- An Evidence-Based Approach to the Surgical Management of Resectable Pancreatic AdenocarcinomaJournal of the American College of Surgeons, 2003
- Recommendation for the Examination of Pancreaticoduodenectomy Specimens Removed from Patients with Carcinoma of the Exocrine PancreasDigestive Surgery, 1999
- Practical grouping of positive lymph nodes in pancreatic head cancer treated by an extended pancreatectomySurgery, 1997